Monitoring drug use
Ruedy, J.
Canadian Medical Association Journal 118(12): 1483
1978
ISSN/ISBN: 0008-4409 PMID: 657042 Document Number: 124722
Document emailed within 1 workday
Related Documents
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Ciorciaro, C.; Hartmann, K.; Stoller, R.; Kuhn, M. 1996: Liver injury caused by coumarin anticoagulants: experience of the IKS (Intercanton Monitoring Station) and the SANZ (Swiss Center for Drug Monitoring) Schweizerische Medizinische Wochenschrift 126(49): 2109-2113
Lagier, G.; Vincens, M.; Castot, A. 1983: Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid Therapie 38(3): 303-318
Zoppi, M.; Török, M.; Stoller-Güleryüz, D.; Winzenried, P.; Marty, H.; Hess, T.; Stucki, P.; Bickel, M.H.; Stocker, F.; Hoigné, R. 1982: Drug side effects as the probable cause of death. Results of the Berne Comprehensive Hospital Drug Monitoring Program Schweizerische Medizinische Wochenschrift 112(49): 1808-1810
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Jaźwińska-Tarnawska, E.; Wiela-Hojeńska, A.; Wolańczyk-Medrala, A.; Patkowski, J.; Nittner-Marszalska, M.; Głowacka, K. 2012: Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center Acta Poloniae Pharmaceutica 69(5): 979-984
Ciorciaro, C.; Hartmann, K.; Kuhn, M. 1998: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) Schweizerische Medizinische Wochenschrift 128(7): 254-258
Frewin, D.B.; Shaw, D.R.; Bochner, F. 1982: Therapeutic drug monitoring: a survey of sub- and supra-therapeutic serum drug levels in a large teaching hospital New Zealand Medical Journal 95(719): 774-776
Sjöqvist, F. 1980: The measurement of psychotherapeutic drug concentrations in biological fluids: utility in clinical trials and practice. Overview by drug classes--clinical monitoring of tricyclic antidepressant plasma concentrations Psychopharmacology Bulletin 16(3): 21-25
Bruni, J.; Wilder, B.J. 1979: Antiepileptic drug monitoring Journal of the Florida Medical Association 66(7): 697-699
Mo, P.S. 1983: Therapeutic drug monitoring Zhonghua Nei Ke Za Zhi 22(3): 176-180
Shaw, L.M.; Brayman, K.L. 1994: FK-506 therapeutic drug monitoring Clinical Chemistry 40(12): 2207-2208
Matsumoto, F.; Takahashi, T.; Morita, M. 1990: Therapeutic drug monitoring of fluoroquinolone Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1217-1222
Mackenzie, S. 1981: Drug level monitoring in children Nursing Times 77(17): 736-737
Patrick, C.H. 1995: Therapeutic drug monitoring in neonates Neonatal Network: Nn 14(2): 21-26
Karande, S.; Gogtay, N.J.; Kshirsagar, N.A. 2003: Improving drug safety monitoring Indian Pediatrics 40(12): 1167-1175
Radziwoń-Zaleska, M.; Matsumoto, H.; Skalski, M.; Androsiuk, W.; Dziklińska, A.; Kunicki, P.K. 2000: Therapeutic drug monitoring in depression Polish Journal of Pharmacology 52(4): 255-266
Paxton, J.W. 1981: Therapeutic drug monitoring and clinical pharmacokinetics Australian and New Zealand Journal of Medicine 11(5): 558-561
Walson, P.D. 1998: Therapeutic drug monitoring in special populations Clinical Chemistry 44(2): 415-419